A Prognostic Model Based on Clinicopathological Features and Inflammation- and Nutrition-Related Indicators Predicts Overall Survival in Surgical Patients With Tongue Squamous Cell Carcinoma

1. Warnakulasuriya, S . Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45(4–5):309–316. doi:10.1016/j.oraloncology.2008.06.002
Google Scholar | Crossref | Medline | ISI2. Siegel, RL, Miller, KD, Jemal, A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7-34. doi:10.3322/caac.21551
Google Scholar | Crossref | Medline3. Chen, W, Zheng, R, Baade, PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115-132. doi:10.3322/caac.21338
Google Scholar | Crossref | Medline | ISI4. Zhang, LW, Li, J, Cong, X, et al. Incidence and mortality trends in oral and oropharyngeal cancers in China, 2005–2013. Cancer Epidemiol. 2018;57:120-126. doi:10.1016/j.canep.2018.10.014
Google Scholar | Crossref | Medline5. Upadhyay, P, Gardi, N, Desai, S, et al. Genomic characterization of tobacco/nut chewing HPV-negative early stage tongue tumors identify MMP10 as a candidate to predict metastases. Oral Oncol. 2017;73:56-64. doi:10.1016/j.oraloncology.2017.08.003
Google Scholar | Crossref | Medline6. Lim, SC, Zhang, S, Ishii, G, et al. Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue. Clin. Cancer Res: Official J Am Association for Cancer Res. 2004;10(1 Pt 1):166-172. doi:10.1158/1078-0432.ccr-0533-3
Google Scholar | Crossref | Medline7. Ebrahimi, A, Gil, Z, Amit, M, et al. Comparison of the American Joint Committee on Cancer N1 versus N2a nodal categories for predicting survival and recurrence in patients with oral cancer: time to acknowledge an arbitrary distinction and modify the system. Head Neck. 2016;38(1):135-139. doi:10.1002/hed.23871
Google Scholar | Crossref | Medline8. Weitzman, SA, Gordon, LI. Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood. 1990;76(4):655-663.
Google Scholar | Crossref | Medline9. Tong, Y, Xie, X, Mao, X, Lei, H, Chen, Y, Sun, P. Low Red blood cell count as an early indicator for myometrial invasion in women with endometrioid endometrial carcinoma with metabolic syndrome. Cancer Manag Res. 2020;12:10849-10859. doi:10.2147/cmar.S271078
Google Scholar | Crossref | Medline10. Lee, YJ, Lee, HR, Nam, CM, Hwang, UK, Jee, SH. White blood cell count and the risk of colon cancer. Yonsei Med J. 2006;47(5):646-656. doi:10.3349/ymj.2006.47.5.646
Google Scholar | Crossref | Medline11. An, X, Ding, PR, Wang, FH, Jiang, WQ, Li, YH. Elevated neutrophil to lymphocyte ratio predicts poor prognosis in nasopharyngeal carcinoma. Tumour Biol: J Int Soc Oncodevelopmental Biol Med. 2011;32(2):317-324. doi:10.1007/s13277-010-0124-7
Google Scholar | Crossref | Medline12. Donskov, F . Immunomonitoring and prognostic relevance of neutrophils in clinical trials. Semin Cancer Biol. 2013;23(3):200-207. doi:10.1016/j.semcancer.2013.02.001
Google Scholar | Crossref | Medline13. He, JR, Shen, GP, Ren, ZF, et al. Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma. Head Neck. 2012;34(12):1769-1776. doi:10.1002/hed.22008
Google Scholar | Crossref | Medline14. Trellakis, S, Bruderek, K, Dumitru, CA, et al. Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. Int J Cancer. 2011;129(9):2183-2193. doi:10.1002/ijc.25892
Google Scholar | Crossref | Medline15. Tsai, YD, Wang, CP, Chen, CY, et al. Pretreatment circulating monocyte count associated with poor prognosis in patients with oral cavity cancer. Head Neck. 2014;36(7):947-953. doi:10.1002/hed.23400
Google Scholar | Crossref | Medline16. Clark, EJ, Connor, S, Taylor, MA, Madhavan, KK, Garden, OJ, Parks, RW. Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma. HPB (Oxford). 2007;9(6):456-460. doi:10.1080/13651820701774891
Google Scholar | Crossref | Medline17. Kitayama, J, Yasuda, K, Kawai, K, Sunami, E, Nagawa, H. Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer. BMC Cancer. 2011;11:64. doi:10.1186/1471-2407-11-64
Google Scholar | Crossref | Medline | ISI18. Wang, B, Jiang, XW, Tian, DL, Zhou, N, Geng, W. Combination of haemoglobin and prognostic nutritional Index predicts the prognosis of postoperative radiotherapy for esophageal squamous cell carcinoma. Cancer Manag Res. 2020;12:8589-8597. doi:10.2147/cmar.S266821
Google Scholar | Crossref | Medline19. Abu-Zaid, A, Alomar, O, Abuzaid, M, Baradwan, S, Salem, H, Al-Badawi, IA. Preoperative anemia predicts poor prognosis in patients with endometrial cancer: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2021;258:382-390. doi:10.1016/j.ejogrb.2021.01.038
Google Scholar | Crossref | Medline20. Bhattathiri, VN . Relation of erythrocyte and iron indices to oral cancer growth. Radiother Oncol. 2001;59(2):221-226. doi:10.1016/s0167-8140(01)00326-7
Google Scholar | Crossref | Medline21. Loreto, MF, De Martinis, M, Corsi, MP, Modesti, M, Ginaldi, L. Coagulation and cancer: implications for diagnosis and management. Pathol Oncol Res. 2000;6(4):301-312. doi:10.1007/bf03187336
Google Scholar | Crossref | Medline22. Lip, GY, Chin, BS, Blann, AD. Cancer and the prothrombotic state. Lancet Oncol. 2002;3(1):27-34. doi:10.1016/s1470-2045(01)00619-2
Google Scholar | Crossref | Medline | ISI23. Honn, KV, Tang, DG, Chen, YQ. Platelets and cancer metastasis: more than an epiphenomenon. Semin Thromb Hemost. 1992;18(4):392-415. doi:10.1055/s-2007-1002578
Google Scholar | Crossref | Medline24. Zhou, Q, Huang, F, He, Z, Zuo, MZ. Clinicopathological and prognostic significance of platelet count in patients with ovarian cancer. Climacteric. 2018;21(1):60-68. doi:10.1080/13697137.2017.1406911
Google Scholar | Crossref | Medline25. Russo, A, Russano, M, Franchina, T, et al. Neutrophil-to-Lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and outcomes with nivolumab in pretreated non-small cell lung cancer (NSCLC): a large retrospective multicenter study. Adv Ther. 2020;37(3):1145-1155. doi:10.1007/s12325-020-01229-w
Google Scholar | Crossref | Medline26. Fang, T, Wang, Y, Yin, X, et al. Diagnostic sensitivity of NLR and PLR in early diagnosis of gastric cancer. J Immunol Res. 2020;2020:9146042. doi:10.1155/2020/9146042
Google Scholar | Crossref | Medline27. Hu, C, Bai, Y, Li, J, et al. Prognostic value of systemic inflammatory factors NLR, LMR, PLR and LDH in penile cancer. BMC Urol. 2020;20(1):57. doi:10.1186/s12894-020-00628-z
Google Scholar | Crossref | Medline28. Zhang, X, Zhao, W, Yu, Y, et al. Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis. World J Surg Oncol. 2020;18(1):191. doi:10.1186/s12957-020-01952-2
Google Scholar | Crossref | Medline29. Templeton, AJ, Ace, O, McNamara, MG, et al. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2014;23(7):1204-1212. doi:10.1158/1055-9965.Epi-14-0146
Google Scholar | Crossref | Medline | ISI30. Li, B, Zhou, P, Liu, Y, et al. Platelet-to-lymphocyte ratio in advanced cancer: review and meta-analysis. Clin Chim Acta. 2018;483:48-56. doi:10.1016/j.cca.2018.04.023
Google Scholar | Crossref | Medline31. Diem, S, Schmid, S, Krapf, M, et al. Neutrophil-to-Lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. Lung Cancer (Amsterdam, Netherlands). 2017;111:176-181. doi:10.1016/j.lungcan.2017.07.024
Google Scholar | Crossref | Medline32. Deng, TB, Zhang, J, Zhou, YZ, Li, WM. The prognostic value of C-reactive protein to albumin ratio in patients with lung cancer. Medicine (Baltimore). 2018;97(50):e13505. doi:10.1097/md.0000000000013505
Google Scholar | Crossref | Medline33. Lin, JX, Lin, JP, Xie, JW, et al. Prognostic importance of the preoperative modified systemic inflammation score for patients with gastric cancer. Gastric Cancer. 2019;22(2):403-412. doi:10.1007/s10120-018-0854-6
Google Scholar | Crossref | Medline34. Ibrahim, UA, Yusuf, AA, Ahmed, SG. The pathophysiologic basis of anaemia in patients with malignant diseases. Gulf J Oncolog. 2016;1(22):80-89.
Google Scholar | Medline35. Anees Ahmed, RA, Ganvir, SM, Hazarey, VK. Relation of erythrocyte indices and serum iron level with clinical and histological progression of oral squamous cell carcinoma in central India. J Investig Clin Dent. 2014;5(1):65-71. doi:10.1111/jicd.12021
Google Scholar | Crossref | Medline36. Raza, U, Sheikh, A, Jamali, SN, Turab, M, Zaidi, SA, Jawaid, H. Post-treatment hematological variations and the role of hemoglobin as a predictor of disease-free survival in stage 2 breast cancer patients. Cureus. 2020;12(3):e7259. doi:10.7759/cureus.7259
Google Scholar | Medline37. Li, Y, Wu, H, Xing, C, et al. Prognostic evaluation of colorectal cancer using three new comprehensive indexes related to infection, anemia and coagulation derived from peripheral blood. J Cancer. 2020;11(13):3834-3845. doi:10.7150/jca.42409
Google Scholar | Crossref | Medline38. Philip, M, Rowley, DA, Schreiber, H. Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol. 2004;14(6):433-439. doi:10.1016/j.semcancer.2004.06.006
Google Scholar | Crossref | Medline39. Elinav, E, Nowarski, R, Thaiss, CA, Hu, B, Jin, C, Flavell, RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;13(11):759-771. doi:10.1038/nrc3611
Google Scholar | Crossref | Medline | ISI40. Olsson, AK, Cedervall, J. The pro-inflammatory role of platelets in cancer. Platelets. 2018;29(6):569-573. doi:10.1080/09537104.2018.1453059
Google Scholar | Crossref | Medline41. Stoiber, D, Assinger, A. Platelet-Leukocyte interplay in cancer development and progression. Cells. 2020;9(4):855. doi:10.3390/cells9040855
Google Scholar | Crossref42. Ong, HS, Gokavarapu, S, Wang, LZ, Tian, Z, Zhang, CP. Low pretreatment lymphocyte-monocyte ratio and high platelet-lymphocyte ratio indicate poor cancer outcome in early tongue cancer. J Oral Maxillofac Surg. 2017;75(8):1762-1774. doi:10.1016/j.joms.2016.12.023
Google Scholar | Crossref | Medline43. Peng, HX, Lin, K, He, BS, et al. Platelet-to-lymphocyte ratio could be a promising prognostic biomarker for survival of colorectal cancer: a systematic review and meta-analysis. FEBS Open Bio. 2016;6(7):742-750. doi:10.1002/2211-5463.12083
Google Scholar | Crossref | Medline44. Graupp, M, Schaffer, K, Wolf, A, et al. C-reactive protein is an independent prognostic marker in patients with tongue carcinoma – A retrospective study. Clin Otolaryngol. 2018;43(4):1050‐1056. doi:10.1111/coa.13102
Google Scholar | Crossref | Medline45. Wu, CN, Chuang, HC, Lin, YT, Fang, FM, Li, SH, Chien, CY. Prognosis of neutrophil-to-lymphocyte ratio in clinical early-stage tongue (cT1/T2N0) cancer. Onco Targets Ther. 2017;10:3917-3924. doi:10.2147/ott.S140800

留言 (0)

沒有登入
gif